MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $127.7 million in its fourth quarter.
The Madison, Wisconsin-based company said it had a loss of 72 cents per share.
The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share.
The molecular diagnostics company posted revenue of $553 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $519.3 million.
For the year, the company reported that its loss widened to $623.5 million, or $3.54 per share. Revenue was reported as $2.08 billion.
Exact Sciences expects full-year revenue in the range of $2.27 billion to $2.32 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a EXAS">Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS